Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × cemiplimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Head & Neck 1 Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 42 Melanoma 19 Squamous Cell Carcinoma of Head and Neck 14 Neoplasms 14 Neoplasm Metastasis 14 Skin Neoplasms 11 Lung Neoplasms 10 Carcinoma, Squamous Cell 8 Carcinoma, Renal Cell 8 Head and Neck Neoplasms 7 Urinary Bladder Neoplasms 6 Recurrence 6 Ovarian Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Merkel Cell 5 Carcinoma, Basal Cell 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Colonic Neoplasms 4 Adenocarcinoma 4 Mycosis Fungoides 3 Glioblastoma 3 Fallopian Tube Neoplasms 3 Cutaneous Squamous Cell Carcinoma 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Uveal Melanoma 2

Interventions

Doxorubicin 120 Ifosfamide 70 Radiotherapy 65 Cyclophosphamide 61 Gemcitabine 53 Filgrastim 46 Trabectedin 36 pazopanib 34 Docetaxel 34 Etoposide 33 pembrolizumab 32 Vincristine 30 Cisplatin 29 Nivolumab 27 Irinotecan 21 Magnetic Resonance Spectroscopy 20 Carboplatin 20 Ipilimumab 19 Surgical Procedures, Operative 18 Radiation 18 Temozolomide 17 Mesna 16 Melphalan 16 Biopsy 16 Bevacizumab 16 Sirolimus 15 Granulocyte Colony-Stimulating Factor 15 Drug Therapy 15 Dactinomycin 15 Blood Specimen Collection 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02423863 2020-12-17

Poly-ICLC

Oncovir, Inc.

Phase 2 Completed

DermatologicHead & NeckSarcoma

Head and Neck Neoplasms, Melanoma, Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡